RxDoctor Payments DataLook up a doctor →

Ardaman Shergill

Medical Oncology · Chicago, ILNPI 1992948152

Payments from drug & device makers

$4,884,083in general payments, 2019–2025

Across 184 payments — averaging $26,544 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2.2M
  • Pfizer$2.1M
  • AbbVie$128K
  • E.r. Squibb & Sons, L.L.C.$78K
  • Macrogenics, Inc.$73K
  • Novartis$65K
  • plus $243K from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,884,083 in reported general payments places this provider in the 95th percentile of 144 medical oncology providers in Illinois.

See all medical oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$45,585
Medicare patients
105
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →